PLUS THERAPEUTICS, INC. (PSTV) › Operating Cash FlowPLUS THERAPEUTICS, INC. (PSTV) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$23.81M2010: -$23.57M2011: -$35.32M2012: -$32.19M2013: -$34.56M2017: -$18.13M2018: -$11.97M2019: -$5.91M2020: -$8.43M2021: -$10.28M2022: -$12.97M2023: -$12.85M2024: -$10.55M2025: -$20.77M-$20.77M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$20.77M-96.8%2024-$10.55M+17.9%2023-$12.85M+0.9%2022-$12.97M-26.2%2021-$10.28M-21.9%2020-$8.43M-42.8%2019-$5.91M+50.7%2018-$11.97M+33.9%2017-$18.13M—2013-$34.56M-7.4%2012-$32.19M+8.9%2011-$35.32M-49.8%2010-$23.57M+1.0%2009-$23.81M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share